AstraZeneca Newark Transformation

Newark, Delaware, United States

Lendlease managed AstraZeneca's (AZ) multi-phased Newark Facility Transformation (NFT) project in Newark, Delaware consisting of the construction of a new oral solid dosage (OSD) formulation suite, and renovations and upgrades to the facility's packaging lines, warehouse and support areas.

AstraZeneca Newark Transformation

Client
AstraZeneca Pharmaceuticals LP
Location
Newark, Delaware, United States
Completion
2017
Area
120,000 square feet
Assignments
Construction Management, Cost Plus
Architect
CRB

Project outcome

All work was performed while the facility remains fully operational.  In March 2016, the Lendlease NFT project team, was awarded a 'Gold Star Safety' at AstraZeneca's Global Engineering's North America Safety awards ceremony.